1-Methyl-1,2,3,4-tetrahydroisoquinoline - CAS 4965-09-7
Catalog: |
BB026766 |
Product Name: |
1-Methyl-1,2,3,4-tetrahydroisoquinoline |
CAS: |
4965-09-7 |
Synonyms: |
1-methyl-1,2,3,4-tetrahydroisoquinoline; 1-methyl-1,2,3,4-tetrahydroisoquinoline |
IUPAC Name: | 1-methyl-1,2,3,4-tetrahydroisoquinoline |
Description: | 1-Methyl-1,2,3,4-tetrahydroisoquinoline (CAS# 4965-09-7) is a useful research chemical. |
Molecular Weight: | 147.22 |
Molecular Formula: | C10H13N |
Canonical SMILES: | CC1C2=CC=CC=C2CCN1 |
InChI: | InChI=1S/C10H13N/c1-8-10-5-3-2-4-9(10)6-7-11-8/h2-5,8,11H,6-7H2,1H3 |
InChI Key: | QPILYVQSKNWRDD-UHFFFAOYSA-N |
Boiling Point: | 239.3 °C at 760 mmHg |
Density: | 0.966 g/cm3 |
MDL: | MFCD00798989 |
LogP: | 2.22210 |
GHS Hazard Statement: | H302 (97.5%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021071843-A1 | Muscarinic acetylcholine m1 receptor antagonists | 20191007 |
WO-2020192560-A1 | Chiral isoquinoline carboxylic acid and preparation method thereof | 20190325 |
WO-2020109224-A1 | Further heteroaromatic compounds having activity against rsv | 20181126 |
EP-3784667-A1 | Heteroaromatic compounds having activity against rsv | 20180423 |
EP-3717486-A1 | Pyrazolopyrimidines having activity against the respiratory syncytial virus (rsv) | 20171129 |
PMID | Publication Date | Title | Journal |
22316420 | 20120208 | Evaluation of blood-brain barrier transport and CNS drug metabolism in diseased and control brain after intravenous L-DOPA in a unilateral rat model of Parkinson's disease | Fluids and barriers of the CNS |
23087137 | 20120101 | Comparative behavioral and neurochemical studies of R- and S-1-methyl-1,2,3,4-tetrahydroisoquinoline stereoisomers in the rat | Pharmacological reports : PR |
21069490 | 20110801 | Both stereoselective (R)- and (S)-1-Methyl-1,2,3,4-tetrahydroisoquinoline enantiomers protect striatal terminals against rotenone-induced suppression of dopamine release | Neurotoxicity research |
21273655 | 20101101 | Important role of 3-methoxytyramine in the inhibition of cocaine sensitization by 1-methyl-1,2,3,4-tetrahydroisoquinoline: an in vivo microdialysis study | Pharmacological reports : PR |
21273661 | 20101101 | 1-Methyl-1,2,3,4-tetrahydroisoquinoline and established uncompetitive NMDA receptor antagonists induce tolerance to excitotoxicity | Pharmacological reports : PR |
Complexity: | 133 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 147.104799419 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 147.104799419 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 12 Å2 |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoline/Isoquinoline
Customers Also Viewed
-
[169689-05-8]
1S,2S-DHAC-Phenyl Trost Ligand
-
[30360-19-1]
N,N'-Diethyl-N''-isopropyl-1,3,5-triazine-2,4,6-triamine
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[1427004-19-0]
DBCO-PEG4-NHS ester
-
[10128-55-9]
N-[2-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]-2-naphthalenesulfonamide
-
[5518-18-3]
N-[2-(hexadecanoylamino)ethyl]hexadecanamide
INDUSTRY LEADERS TRUST OUR PRODUCTS